Latest Articles

Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early

Act Now for Your ACS Patients: Summary

Act Now for Your ACS Patients: Patient Identification

Public health recommendations for Lp(a) measurement

iGlarLixi Enables Safe Ramadan Fasting for Most T2D Patients

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Diabetes management during Ramadan

Closed-loop insulin delivery during exercise in people with T1DM

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.